Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,503.52
(
0.80%
)
US TECH 100
28,838.40
(
0.87%
)
Dow Jones
50,160.09
(
0.94%
)
Brent Oil
102.91
(
-0.76%
)
Bitcoin
81,580.96
(
2.90%
)
News Focus
News Focus
Post# of 257560
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

super_trades

Send PM Follow Ignore
Followers 46
Posts 1658
Boards Moderated 0
Alias Born 09/01/2013

super_trades

Re: None

Wednesday, 04/20/2016 9:17:48 AM

Wednesday, April 20, 2016 9:17:48 AM

Post# of 257560
TRIL - Stanford is presenting human cd47 data at ASCO from P1

Abstract 3019
A first-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers.

Poster Board: #341
Discussed at the Poster Discussion Session on Sunday, June 5, 2016 4:45 PM - 6:00 PM, at Hall B1
Branimir I. Sikic, MD - Presenter
Stanford University School of Medicine


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today